Eden Research plc (LON:EDEN – Get Free Report) shot up 18.4% on Tuesday. The stock traded as high as GBX 2.90 and last traded at GBX 2.90. Approximately 3,891,780 shares were traded during trading, an increase of 598% from the average daily volume of 557,270 shares. The stock had previously closed at GBX 2.45.
Eden Research Price Performance
The company has a current ratio of 1.95, a quick ratio of 2.42 and a debt-to-equity ratio of 5.41. The company has a market capitalization of £24.10 million, a PE ratio of -6.77 and a beta of 1.61. The stock’s 50-day moving average is GBX 2.31 and its two-hundred day moving average is GBX 3.05.
Eden Research (LON:EDEN – Get Free Report) last announced its earnings results on Wednesday, August 26th. The company reported GBX (0.36) EPS for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. On average, equities analysts predict that Eden Research plc will post -66.00 EPS for the current year.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.
See Also
- Five stocks we like better than Eden Research
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
- Enphase Energy’s Solar Slump Raises a Question About Its AI Data Center Ambitions
- 1 Frozen Housing Market, 2 Very Different Earnings Stories
- 3 Energy Stocks Boosting Dividends as the Sector Widens Its 2026 Performance Lead
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
